Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1556-276X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer ; volume:14 ; number:1 ; day:14 ; month:3 ; year:2019 ; pages:1-11 ; date:12.2019
Nanoscale research letters ; 14, Heft 1 (14.3.2019), 1-11, 12.2019
- Creator
-
Zhang, Ruiguo
Zhang, Yueqian
Tan, Jian
Wang, Hanjie
Zhang, Guizhi
Li, Ning
Meng, Zhaowei
Zhang, Fuhai
Chang, Jin
Wang, Renfei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s11671-019-2924-z
- URN
-
urn:nbn:de:101:1-2019040716424339952158
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Ruiguo
- Zhang, Yueqian
- Tan, Jian
- Wang, Hanjie
- Zhang, Guizhi
- Li, Ning
- Meng, Zhaowei
- Zhang, Fuhai
- Chang, Jin
- Wang, Renfei
- SpringerLink (Online service)
Other Objects (12)
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab')2 on epithelial ovarian cancer cell lines
Consequences of VEGFR2 ablation during development
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
124I-Radiojodtest : Vergleich des prätherapeutischen 124I- und 131I-Uptakes mit dem intratherapeutischen 131I-Uptake bei benignen Schilddrüsenerkrankungen
Kernresonanz an orientiertem 60Co [Co], 131I [I], 183Re [Re], 183Os [Os] und Relaxationsmessungen an 131I [I] in Eisen
Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
VEGFR2 function during neuronal development and synaptic plasticity
Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab')2 on epithelial ovarian cancer cell lines
Consequences of VEGFR2 ablation during development
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
124I-Radiojodtest : Vergleich des prätherapeutischen 124I- und 131I-Uptakes mit dem intratherapeutischen 131I-Uptake bei benignen Schilddrüsenerkrankungen
Kernresonanz an orientiertem 60Co [Co], 131I [I], 183Re [Re], 183Os [Os] und Relaxationsmessungen an 131I [I] in Eisen
Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
VEGFR2 function during neuronal development and synaptic plasticity
Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab')2 on epithelial ovarian cancer cell lines
Consequences of VEGFR2 ablation during development
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
124I-Radiojodtest : Vergleich des prätherapeutischen 124I- und 131I-Uptakes mit dem intratherapeutischen 131I-Uptake bei benignen Schilddrüsenerkrankungen
Kernresonanz an orientiertem 60Co [Co], 131I [I], 183Re [Re], 183Os [Os] und Relaxationsmessungen an 131I [I] in Eisen
Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
VEGFR2 function during neuronal development and synaptic plasticity